Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aziyo Biologics Q1 EPS $(0.49) Beats $(0.54) Estimate, Sales $13.05M Miss $13.70M Estimate

Author: Benzinga Newsdesk | May 10, 2023 04:14pm
Aziyo Biologics (NASDAQ:AZYO) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.54) by 9.26 percent. This is a 18.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $13.05 million which missed the analyst consensus estimate of $13.70 million by 4.74 percent. This is a 13.53 percent increase over sales of $11.49 million the same period last year.

Posted In: AZYO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist